Autor: "Buti S" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status.
Autorzy:: Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. .; Division of Cancer, Department of Surgery and Cancer, ICTEM Building, Hammersmith Hospital, Imperial College London, Du Cane Road, London, W12 0HS, UK. .
Giusti R; Medical Oncolgy, St. Andrea Hospital, Rome, Italy.
Filetti M; Medical Oncolgy, St. Andrea Hospital, Rome, Italy.
Citarella F; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Adamo V; Medical Oncology, A.O. Papardo and Department of Human Pathology, University of Messina, Messina, Italy.
Santini D; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
Nigro O; Medical Oncology, ASST-Sette Laghi, Varese, Italy.
Cantini L; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
Di Maio M; Department of Oncology, University of Turin and Medical Oncology, AO Ordine Mauriziano, Turin, Italy.
Aerts JGJV; Department of Pulmonary Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.
Bria E; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Romae, Lazio, Italy.
Bertolini F; Dipartimeto Di Oncologia Ed Ematologia, AOU Policlinico Modena, Modena, Italy.
Ferrara MG; Comprehensive Cancer Center, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Romae, Lazio, Italy.
Ghidini M; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Grossi F; Division of Medical Oncology, University of Insubria, Varese, Italy.
Guida A; Struttura Complessa Di Oncologia Medica E Traslazionale, Azienda Ospedaliera Santa Maria Di Terni, Terni, Italy.
Berardi R; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
Morabito A; Thoracic Medical Oncology, Istituto Nazionale Tumori 'Fondazione G Pascale', IRCCS, Napoli, Italy.
Genova C; UOC Clinica Di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Dipartimento Di Medicina Interna E Specialità Mediche, Università Degli Studi Di Genova, Genoa, Italy.
Mazzoni F; Department of Oncology, Careggi University Hospital, Florence, Italy.
Antonuzzo L; Department of Oncology, Careggi University Hospital, Florence, Italy.
Gelibter A; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
Marchetti P; Department of Clinical and Molecular Medicine, Sapienza University, Rome, Italy.
Chiari R; Medical Oncology, Ospedali Riuniti Padova Sud 'Madre Teresa Di Calcutta', Monselice, Italy.
Macerelli M; Department of Oncology, University Hospital Santa Maria Della Misericordia, Udine, Italy.
Rastelli F; Medical Oncology, Fermo Area Vasta 4, Fermo, Italy.
Della Gravara L; Pneumo-Oncology Unit, Monaldi Hospital, Naples, Italy.
Gori S; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, VR, Italy.
Tuzi A; Medical Oncology, ASST-Sette Laghi, Varese, Italy.
De Tursi M; Dipartimento Di Terapie Innovative in Medicina E Odontoiatria, Università G. D'Annunzio, Chieti-Pescara, Chieti, Italy.
Di Marino P; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
Mansueto G; Medical Oncology, F. Spaziani Hospital, Frosinone, Italy.
Pecci F; Oncology Clinic, Università Politecnica Delle Marche, Ospedali Riuniti Di Ancona, Ancona, Italy.
Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
Ricciardi S; Pneumo-Oncology Unit, St. Camillo-Forlanini Hospital, Rome, Italy.
Migliorino MR; Pneumo-Oncology Unit, St. Camillo-Forlanini Hospital, Rome, Italy.
Passiglia F; Department of Oncology, University of Turin, San Luigi Hospital, Orbassano, TO, Italy.
Metro G; Department of Medical Oncology, Santa Maria Della Misericordia Hospital, Azienda Ospedaliera Di Perugia, Perugia, Italy.
Spinelli GP; UOC Territorial Oncology, AUSL Latina - CdS Aprilia, Aprilia, Italy.
Banna GL; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Turin, Italy.
Friedlaender A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
Addeo A; Oncology Department, University Hospital of Geneva, Geneva, Switzerland.
Ficorella C; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Porzio G; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Tiseo M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Russano M; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Russo A; Medical Oncology, A.O. Papardo and Department of Human Pathology, University of Messina, Messina, Italy.
Pinato DJ; Division of Cancer, Department of Surgery and Cancer, ICTEM Building, Hammersmith Hospital, Imperial College London, Du Cane Road, London, W12 0HS, UK.; Department of Translational Medicine, Università del Piemonte Orientale 'A. Avogadro', Novara, Italy.; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2022 Jan 21; Vol. 15 (1), pp. 9. Date of Electronic Publication: 2022 Jan 21.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't
MeSH Terms:: Immunotherapy*
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Carcinoma, Non-Small-Cell Lung/genetics ; DNA Damage ; Female ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Lung Neoplasms/genetics ; Male ; Treatment Outcome

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
Autorzy:: Santini D; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Zeppola T; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Russano M; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Citarella F; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Anesi C; Medical Oncology, Campus Bio-Medico University, Rome, Italy.
Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
Tucci M; Medical Oncology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.; National Cancer Research Center, Tumori Institute IRCCS Giovanni PaoloII, Bari, Italy.
Russo A; Medical Oncology, A.O. Papardo & Department of Human Pathology, University of Messina, Messina, Italy.
Sergi MC; Medical Oncology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
Adamo V; Medical Oncology, A.O. Papardo & Department of Human Pathology, University of Messina, Messina, Italy.
Stucci LS; Medical Oncology Unit, Department of Biomedical Sciences and Human Oncology, University of Bari, Bari, Italy.
Bersanelli M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Mazzaschi G; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
Spagnolo F; IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Rastelli F; UOC Oncologia Ascoli Piceno - San Benedetto del Tronto, Area Vasta 5, ASUR Marche, Ancona, Italy.
Giorgi FC; UOC Oncologia Ascoli Piceno - San Benedetto del Tronto, Area Vasta 5, ASUR Marche, Ancona, Italy.
Giusti R; Medical Oncology Unit, Sant' Andrea Hospital of Rome, Rome, Italy.
Filetti M; Medical Oncology Unit, Sant' Andrea Hospital of Rome, Rome, Italy.
Marchetti P; Medical Oncology Unit, Sant' Andrea Hospital of Rome, Rome, Italy.; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
Botticelli A; Department of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
Gelibter A; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
Siringo M; Medical Oncology (B), Policlinico Umberto I, 'Sapienza' University of Rome, Rome, Italy.
Ferrari M; Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Marconcini R; Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Vitale MG; Medical Oncology, University Hospital of Modena, Modena, Italy.
Nicolardi L; UOC Oncologia Padova Sud - AULSS6 Euganea, Padova, Italy.
Chiari R; UOC Oncologia Padova Sud - AULSS6 Euganea, Padova, Italy.
Ghidini M; Medical Oncology Unit, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan, Italy.
Nigro O; Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
Grossi F; Division of Medical Oncology, University of Insubria, Varese, Italy.
De Tursi M; Department of Medical, Oral & Biotechnological Sciences, University G. D'Annunzio, Chieti-Pescara, Italy.
Di Marino P; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
Pala L; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Queirolo P; Division of Medical Oncology for Melanoma, Sarcoma, and Rare Tumors, IEO, European Institute of Oncology IRCCS, Milan, Italy.
Bracarda S; S.C. Medical Oncology, Azienda Ospedaliera S. Maria, Terni, Italy.
Macrini S; S.C. Medical Oncology, Azienda Ospedaliera S. Maria, Terni, Italy.
Gori S; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, VR, Italy.
Inno A; Oncology Unit, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar, VR, Italy.
Zoratto F; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
Tanda ET; IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Genetics of Rare Cancers, Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.
Mallardo D; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.
Vitale MG; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.
Talbot T; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.
Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori-IRCCS Fondazione 'G. Pascale', Naples, Italy.
Pinato DJ; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.; Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
Ficorella C; Medical Oncology Unit, St. Salvatore Hospital, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Porzio G; Medical Oncology Unit, St. Salvatore Hospital, L'Aquila, Italy.
Cortellini A; Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK. .; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2021 Jun 24; Vol. 19 (1), pp. 270. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: B7-H1 Antigen*
Lung Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors ; Italy ; Programmed Cell Death 1 Receptor

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Family history of cancer and DNA damage response genes: Two sides of the same coin?
Autorzy:: Cortellini A; Department of Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Bersanelli M; Department of Medical Oncology, University Hospital of Parma, Parma, Italy.
Ficorella C; Department of Medical Oncology, St. Salvatore Hospital, University of L'Aquila, L'Aquila, Italy.; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Buti S; Department of Medical Oncology, University Hospital of Parma, Parma, Italy.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2019 Feb; Vol. 10 (2), pp. 401. Date of Electronic Publication: 2018 Dec 08.
Typ publikacji:: Letter; Comment
MeSH Terms:: Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*
B7-H1 Antigen ; Biomarkers ; DNA Damage ; Humans ; Immunotherapy ; Programmed Cell Death 1 Receptor

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Buti S"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język